FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/01/030500 [Registered on: 15/01/2021] Trial Registered Prospectively
Last Modified On: 10/01/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   To compare two drugs when used with a local anesthetic for upper limb surgeries 
Scientific Title of Study   Comparative study between Tramadol and Butorphanol as an adjuvant to Bupivacaine for supraclavicular brachial plexus block. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Niyati Garg 
Designation  post graduate trainee 1st year 
Affiliation  kalinga institue of medical sciences 
Address  KIMS girls hostel, B Block,campus 5, KIIT university, Patia, Distt Khorda, Bhubaneswar

Khordha
ORISSA
751024
India 
Phone  9958787244  
Fax    
Email  gargn58@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Brig Dr Ganesh Chandra Satapathy 
Designation  Prof & HOD, Dept of anesthesiology, KIMS, bhubaneswar 
Affiliation  kalinga institue of medical sciences, bhubaneswar 
Address  Department of Anesthesia, Kalinga Institute of Medical Sciences, Bhubaneswar

Khordha
ORISSA
751024
India 
Phone  8283872939  
Fax    
Email  ganesh.satapathy@kims.ac.in  
 
Details of Contact Person
Public Query
 
Name  Niyati Garg 
Designation  post graduate trainee 1st year 
Affiliation  kalinga institue of medical sciences 
Address  Department of Anaesthesiology, KIMS girls hostel, B block campus 5, KIIT university, Patia, Distt Khorda, Bhubaneswar

Khordha
ORISSA
751024
India 
Phone    
Fax    
Email  gargn58@gmail.com  
 
Source of Monetary or Material Support  
Kalinga institute of medical sciences 
 
Primary Sponsor  
Name  Self 
Address  KIMS girls hostel, campus 5 KIIT university, Patia Distt Khorda, Bhubaneswar 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Niyati Garg  Kalinga Institute of Medical Sciences  Department of Anaesthesiology, KIIT campus 5, B Block, Patia, distt Khorda, Bhubaneswar-751024
Khordha
ORISSA 
9958787244

gargn58@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M849||Disorder of continuity of bone, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  supraclavicular block  frequency-once route of administration- supraclavicular under ultrasound guidance dose- 1.Group T will receive 0.5% Bupivacaine 25 mL with 50 mg Tramadol (1 mL) titrated to 30 mL, and 2.Group B will receive 0.5% Bupivacaine 25 mL with 1 mg Butorphanol (1 mL) titrated to 30 mL  
Intervention  supraclavicular brachial plexus block  Two opioid adjuvants will be added to local anesthetic in supraclavicular block for post operative pain management  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  ASA-PS I and II patients posted for upper limb orthopedic surgeries under Supraclavicular brachial plexus block.
 
 
ExclusionCriteria 
Details  Patient refusal,
Morbidly obese patients (body mass index >35 kg/m2),
Pregnant or lactating women,
Allergy or addiction to study drugs,
Patients receiving chronic analgesic therapy,
Coagulopathies, and
Pre-existing peripheral neuropathy 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To study the onset and duration of sensory and motor blockade.

 
1.5 years 
 
Secondary Outcome  
Outcome  TimePoints 
To study duration of postoperative analgesia, requirements of rescue analgesia, and drug-related adverse effects in Supraclavicular Brachial plexus block.  1.5 years 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   21/01/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Brachial plexus block is widely used as an alternative to general anesthesia for upper limb surgeries. In this study, one group will receive Tramadol with Bupivacaine and the second group will receive Butorphanol with Bupivacaine. Both groups will be compared on the basis of onset and duration of motor and sensory block, duration of post operative analgesia, requirements of rescue analgesia and drug related adverse effects. 
Close